Register


Create a profile to access all of our events, including options to sign up for our in person meetings and to view the online content from our past conferences!


Video Platform

View all the content from the last 12 months

MD Newsletter

Stay up to date with everything MD Education

Tickets & Events

Save your space and register for our future events

Select what applies to you




Login

Gaining access to MD Education’s premium offerings is only a button away! Enter your email and password to get educated.

MD-Education logo
Register / Login
We're evolving!

The website is currently being upgraded to include our new suite of offerings. Check back at the end of the month for a breakdown of our new services!


Questions? Contact us at:


office@md-education.com

Want Cookies?


Currently, we're using cookies for tracking purposes. By tracking, we mean what pages of MD Education you visit, what forms you submit and how you interact with our site. We do not sell this data to anybody. Currently, the Cookies we use are needed to collect form data through HubSpot.


If you'd like to see what we do with your data, head over to our Privacy Policy


Inaugural

Thank you for registering to our ASH Satillite Symposium!

Please check your emails for registration confirmation.


Multiple Myeloma

US Focus Meeting

Updating Knowledge & Clinical Practice in 2025


Hilton Boston Back Bay, 40 Dalton St, Boston, MA 02115

August 15, 2025

Interested in supporting this meeting? Reach out to us here:

=

Co-chair

Noopur Raje, MD

Massachusetts General Hospital, Boston, MA

=

Co-chair

Shaji Kumar, MD

Mayo Clinic, Rochester, MN

Dear Colleagues and Friends,


We are delighted to extend our warmest invitation to the multinational congress Multiple Myeloma US Focus 2025, to be held at Hilton Boston Back Bay, 40 Dalton St, Boston, MA 02115 on August 15th, 2025.


This meeting provides pivotal collaboration aimed at advancing Multiple Myeloma research and patient treatment.


This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts from around the world.


Engage in riveting presentations, participate in thought-provoking debates, round-table discussions, and connect with peers at informal social gatherings.



People stood in a circle, smiling, with a cup of water

Agenda & Faculty

Multiple Myeloma US Focus Meeting, Friday, August 15, 2025

7:30 AM

Registration Opens

Session 1: Novel Diagnostic Platforms and Precursor Disease States

8:30 AM

Replacing FISH with Sequencing Platforms

=

Nikhil Munshi, MD

Dana-Farber Cancer Institute, Boston, MA

8:50 AM

Role of Mass Spectrometry in Diagnosis and Monitoring

=

David Murray, MD

Mayo Clinic, Rochester, MN

9:10 AM

The Immune Landscape in Precursor Disease

=

Madhav V. Dhodapkar, MD

Winship Cancer Institute of Emory University, GA

9:30 AM

How I Manage MGUS and SMM

=

Natalie Callander, MD

UW Health, Madison, WI

9:50 AM

Panel Discussion

10:10 AM

Coffee Break

Session 2: Newly Diagnosed Multiple Myeloma

10:30 AM

Quadruplets for ALL?

=

Ajay Nooka, MD

Winship Cancer Institute of Emory University, Atlanta, GA

10:50 AM

Defining Frailty and Treatment of Frail Patients

=

Ashley Rosko, MD

The Ohio State University, Columbus, OH

11:10 AM

Tailoring the Maintenance Regimen and Duration

=

Amrita Krishnan, MD

City of Hope Comprehensive Cancer Center, Duarte, CA

11:30 AM

Challenges and Opportunities in Newly Diagnosed Multiple Myeloma

=

Melissa Alsina, MD

Moffitt Cancer Center, Tampa, FL

11:50 AM

Panel Discussion

12:10 PM

Lunch Break + Faculty and Fellow Photo

Session 3: High Risk Disease

1:00 PM

Defining High Risk Disease

=

Wilson Gonsalves, MD

Mayo Clinic, Rochester, MN

1:20 PM

Should High Risk Disease be Treated Differently?

=

Saad Usmani, MD

Memorial Sloan Kettering Cancer Center, Montvale, NJ

1:40 PM

Clinical Trials Targeting High Risk Disease

=

Robert Orlowski, MD

MD Anderson Cancer Center, Houston, TX

2:00 PM

Panel Discussion

2:20 PM

Coffee Break

Session 4: Relapse MM

2:40 PM

Approaching Disease Relapse – Treatment Approaches Excluding Immunotherapies

=

Joshua Richter, MD

Icahn School of Medicine at Mount Sinai, New York, NY

3:00 PM

Belamaf: The Comeback Kid?

=

Sagar Lonial, MD

Winship Cancer Institute of Emory University, Atlanta, GA

3:20 PM

Targeted therapy in RR MM: BCL2i, MMSET, BRAF

=

Andrew Yee, MD

Massachusetts General Hospital, Boston, MA

3:40 PM

Incorporating Celmods in the treatment of MM

=

Suzanne Lentzsch, MD

Herbert Irving Comprehensive Cancer Center, New York, NY

4:00 PM

Panel Discussion

4:20 PM

Coffee Break

Session 5: Immunotherapies in MM

4:40 PM

Use of Bispecifics in MM

=

Anita D’Souza, MD

Medical College of Wisconsin, Wauwatosa, WI

5:00 PM

CAR-T Cells in MM

=

Krina Patel, MD

MD Anderson Cancer Center, Houston, TX

5:20 PM

Novel Targets and Newer Approaches

=

Tom Martin, MD

UCSF, San Francisco, CA

5:40 PM

Panel Discussion

6:00 PM

Coffee Break

6:20 PM

AL Amyloidosis

=

Vaishali Sanchorawala, MD

Boston Medical Center, Boston, MA

6:40 PM

Waldenstroms

=

Steven Treon, MD

Dana-Farber Cancer Institute, Boston, MA

7:00 PM

Panel Discussion

7:20 PM

Adjourn